Moberg Pharma AB (publ) (STO:MOB)

Sweden flag Sweden · Delayed Price · Currency is SEK
7.55
+0.20 (2.72%)
May 13, 2025, 5:29 PM CET
-76.03%
Market Cap 343.20M
Revenue (ttm) 12.86M
Net Income (ttm) -251.38M
Shares Out 46.69M
EPS (ttm) -5.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 151,638
Average Volume 73,831
Open 7.52
Previous Close 7.35
Day's Range 7.49 - 7.82
52-Week Range 6.34 - 39.78
Beta 0.73
RSI 50.78
Earnings Date May 13, 2025

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 10
Stock Exchange Nasdaq Stockholm
Ticker Symbol MOB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.